Turn Therapeutics share price logo

Turn Therapeutics Share Price

NASDAQ: TTRX

Small Cap

$3.40

-0.02

(-0.58%)

as on

Turn Therapeutics Stock Performance

as on March 25, 2026 at 6:58 am IST

  • Day's Low

    Day's High

    $3.20
    $3.45
    downward going graph

    5.88%

    Downside

    1.47%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Turn Therapeutics share price movements today

Previous Close
$3.42
Open
$3.43
Volume
197.3K
Day's Low - High
$3.20 - $3.45

Turn Therapeutics Historical Returns

1 Month Return
-1.72 %
3 Month Return
+ 15.15 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Turn Therapeutics Stock Fundamentals & Key Indicators

Check Turn Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$101.3M

EPS (TTM)

-0.13

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-2324.83%

Turn Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Turn Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Turn Therapeutics image
Turn Therapeutics
NA$101.3MNANA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Turn Therapeutics Stock’s Investor Sentiment and Interest

Search interest for Turn Therapeutics Stock has increased by 250% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:250% versus previous 30 day period

Turn Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Jun 2025
Total Revenue
-
-
Gross Profit
-
-
Operating Income
0
-1
EBITDA
0
-1
Interest Expense
-
-
Depreciation
-
-
Income Before Tax
0
-1
Income Tax Expense
-
-
Net Income
0
-1
Net Profit Margin
0.00%
0.00%

Turn Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-2
-1
EBITDA
-2
-1
Interest Expense
-
-
Depreciation
0
0
Income Before Tax
-2
-1
Income Tax Expense
-
-
Net Income
-2
-1
Net Profit Margin
0.00%
0.00%

Turn Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Jun 2025
Net Income
-1
Operating Cash Flow
-
Investing Cash Flow
-
Financing Cash Flow
-
Change in Cash
-

Turn Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2024
Net Income
-1
Operating Cash Flow
-1
Investing Cash Flow
0
Financing Cash Flow
1
Change in Cash
0

Insights on Turn Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, TTRX stock has moved up by 15.2%

About Turn Therapeutics

Turn Therapeutics Inc. is a pharmaceutical and medical device development company built around a proprietary platform of technology designed to enhance drug performance. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.
OrganisationTurn Therapeutics
Headquarters250 N Westlake Blvd, Westlake Village, CA, United States, 91362
CEOMr. Bradley E. Burnam
E-voting on sharesClick here to vote

Key Management of Turn Therapeutics

Name

Title

Mr. Bradley E. Burnam

Founder, CEO & Director

Dr. Neilesh Shailesh Ghodadra M.D.

Chief Medical Officer & Director

Mr. Zuraiz Chaudhary

Interim CFO, VP of Finance & Chief Accounting Officer

Mohammed Zubair

Controller

FAQs

What is Turn Therapeutics share price today?

Turn Therapeutics share price today is $3.4 as on at the close of the market. Turn Therapeutics share today touched a day high of $3.45 and a low of $3.2.

What is the 52 week high and 52 week low for Turn Therapeutics share?

Turn Therapeutics share touched a 52 week high of $ on and a 52 week low of $ on . Turn Therapeutics stock price today i.e. is closed at $3.4,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Turn Therapeutics's market capitalisation today?

Turn Therapeutics market capitalisation is $0.00T as on .

How to invest in Turn Therapeutics Stock (TTRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Turn Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Turn Therapeutics Shares that will get you 0.4412 shares as per Turn Therapeutics share price of $3.4 per share as on March 25, 2026 at 1:28 am IST.

What is the minimum amount required to buy Turn Therapeutics Stock (TTRX) from India?

Indian investors can start investing in Turn Therapeutics (TTRX) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Turn Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Turn Therapeutics share’s latest price of $3.4 as on March 25, 2026 at 1:28 am IST, you will get 2.9412 shares of Turn Therapeutics. Learn more about fractional shares .